| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/05/2012 | CA2799472A1 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 01/04/2012 | EP2402443A2 Therapeutic uses of inhibitors of rtp801 |
| 01/04/2012 | EP2402020A1 Pharmaceutical composition comprising extracts of Bupleurum with immunomodulating function |
| 01/04/2012 | EP2401262A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2401261A1 N-phenylacetamide derivatives, which inhibit the enzyme soat-1 and pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2400977A1 Peptidomimetic cyclic compounds for treating retinitis pigmentosa |
| 01/04/2012 | EP2400970A1 Pde 1 inhibitors for ophthalmic disorders |
| 01/04/2012 | EP2400958A1 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa |
| 01/04/2012 | CN1954855B Eye preparation containing sodium hyaluronate for treating fundus macular degeneration and its preparation method |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307870A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease |
| 01/04/2012 | CN102307621A Novel cyanopyrimidine derivative |
| 01/04/2012 | CN102304124A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/04/2012 | CN102302686A Medicament for treating xerophthalmia |
| 01/04/2012 | CN102302530A Medicinal liquor and preparation method thereof |
| 01/04/2012 | CN102302525A Gingko leaf composition and preparation method thereof |
| 01/04/2012 | CN102302514A Pig blood deproteinized extract gel and preparation method thereof |
| 01/04/2012 | CN102302510A Medicinal composition and application thereof |
| 01/04/2012 | CN102302494A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 01/04/2012 | CN102302481A Medicine composition for treating fungal keratitis |
| 01/04/2012 | CN101979040B Medicament for treating central serous chorioretinopathy |
| 01/04/2012 | CN101972224B Eye in-situ gel |
| 01/04/2012 | CN101773553B Semiaquilegia root extract, preparation method and application thereof |
| 01/04/2012 | CN101444551B Rhizoma atractylodis arborinol inclusion compound, medicinal combination thereof and preparation method |
| 01/04/2012 | CN101292741B Health care bamboo salt with mind pacifying and digestion promoting function, and method of preparing the same |
| 01/03/2012 | US8088934 Composition and method for stabilizing the same |
| 01/03/2012 | US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof |
| 01/03/2012 | US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/03/2012 | US8088407 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 01/03/2012 | CA2661197C Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 01/03/2012 | CA2489128C 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
| 01/03/2012 | CA2486712C Method of treating diabetes |
| 01/03/2012 | CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 01/03/2012 | CA2395684C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/03/2012 | CA2362507C Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 01/03/2012 | CA2331257C Use of tetracyclines for treating meibomian gland disease |
| 01/03/2012 | CA2264562C Sustained peptide-release formulation |
| 01/03/2012 | CA2227265C Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
| 01/03/2012 | CA2210998C Inhibition of neovascularization using vegf-specific oligonucleotides |
| 01/02/2012 | CA2745113A1 Nutritional or dietary supplement composition and methods for using same for treating visual acuity loss |
| 12/29/2011 | WO2011163502A1 Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| 12/29/2011 | WO2011163452A2 Treating surface of the eye disorders |
| 12/29/2011 | WO2011162267A1 Novel thiophenecarboxamide derivatives and use thereof as medicine |
| 12/29/2011 | WO2010129138A3 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment |
| 12/29/2011 | US20110319488 Anionic oil-in-water emulsions containing prostaglandins and uses thereof |
| 12/29/2011 | US20110319487 Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives |
| 12/29/2011 | US20110319479 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 12/29/2011 | US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
| 12/29/2011 | US20110319463 Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients |
| 12/29/2011 | US20110319454 Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| 12/29/2011 | US20110319440 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds |
| 12/29/2011 | US20110319436 Methods and Compositions for Modulating IRE1, SRC, and ABL Activity |
| 12/29/2011 | US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 12/29/2011 | US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor |
| 12/29/2011 | US20110319408 Methods of Treating Fibrosis, Cancer and Vascular Injuries |
| 12/29/2011 | US20110319390 6-Aminoisoquinoline Compounds |
| 12/29/2011 | US20110319377 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| 12/29/2011 | US20110319375 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| 12/29/2011 | US20110319374 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| 12/29/2011 | US20110319373 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| 12/29/2011 | US20110319370 Combination Hormone Therapy for the Eye |
| 12/29/2011 | US20110319368 Once daily formulations of tetracyclines |
| 12/29/2011 | US20110319356 Methods Of Treating Optic Disorders |
| 12/29/2011 | US20110319326 Derivatives of benzothiazines, preparation thereof and application thereof as drugs |
| 12/29/2011 | US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1 |
| 12/29/2011 | US20110318424 METHODS FOR PROLONGING VIABILITY OF CONE CELLS USING MODULATORS OF THE MAMMALIAN TARGET OF RAPAMYCINE (mTOR) |
| 12/29/2011 | US20110318393 Substituted Pyrazole Compounds |
| 12/29/2011 | US20110318365 Methods for treatment of degenerative disease associated with apoptosis |
| 12/29/2011 | US20110318340 Deglycosylated antibodies |
| 12/29/2011 | US20110318307 Xiap therapy |
| 12/29/2011 | US20110318303 Il-10 and methods of treating ocular and other diseases |
| 12/29/2011 | CA2836445A1 Methods of treating optic disorders |
| 12/29/2011 | CA2803920A1 Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| 12/28/2011 | EP2399917A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same |
| 12/28/2011 | EP2399555A1 Sustainedly drug-releasing hydrogel contact lens, and drug releasing method using sustainedly drug-releasing hydrogel contact lens |
| 12/28/2011 | EP2398325A1 Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids |
| 12/28/2011 | EP2170332B1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 12/28/2011 | EP1872783B1 Therapeutic agent for corneal/conjunctival disorder |
| 12/28/2011 | CN102300870A 低分子量多硫酸化透明质酸衍生物和含有它的医药 Low molecular weight sulfated hyaluronic acid derivative and its pharmaceutical containing |
| 12/28/2011 | CN102293933A 一种治疗儿童近视的药物及其制备方法 And preparation of a drug for the treatment of myopia in children |
| 12/28/2011 | CN102293921A 一种治疗耳聋的中药组合物 A therapeutic herbal composition deafness |
| 12/28/2011 | CN102293908A 一种治疗家畜中耳炎的中药组合物 A therapeutic herbal composition of livestock otitis media |
| 12/28/2011 | CN102293856A 菊麻明目丸 Ma Ju eyesight pill |
| 12/28/2011 | CN102293774A 前列腺素F2α衍生物的应用 Prostaglandin F2α derivatives |
| 12/28/2011 | CN101925572B 二氢化茚酰胺化合物制备方法、包含其的药物组合物、及其作为蛋白激酶抑制剂的应用 Indane amide compound preparation, pharmaceutical compositions containing them, their use as protein kinase inhibitors |
| 12/28/2011 | CN101679328B 老年黄斑变性的预防或治疗剂 Age-related macular degeneration prophylactic or therapeutic agent |
| 12/28/2011 | CN101316600B 对干眼综合征的治疗和预防有效的组合物 Of dry eye syndrome treatment and prevention effective compositions |
| 12/28/2011 | CN101007000B 异黄酮化合物的制药用途以及含有它们的组合物 Isoflavone compounds and pharmaceutical use of the compositions containing them |
| 12/27/2011 | US8086277 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system |
| 12/27/2011 | US8084054 Bioerodible film for ophthalmic drug delivery |
| 12/27/2011 | US8084049 Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/27/2011 | US8084031 Method for the treatment of inflammatory disorders |
| 12/23/2011 | CA2744428A1 Nutritional or dietary supplement composition and methods for using same for treating visual acuity loss |
| 12/22/2011 | WO2011159881A2 Il-10 and methods of treating ocular and other diseases |
| 12/22/2011 | WO2011159761A2 Punctal plugs with continuous or pulsatile drug release mechanism |
| 12/22/2011 | WO2011159755A2 Punctal plugs with continuous or pulsatile drug release mechanism |
| 12/22/2011 | WO2011157798A1 Methods and compositions for stimulating reepithelialisation during wound healing |
| 12/22/2011 | WO2011157059A1 Use of isoacteoside or pharmaceutically acceptable saltthereof |
| 12/22/2011 | WO2011097577A9 Compositions and methods for treating or preventing retinal degeneration |
| 12/22/2011 | US20110313058 Method and apparatus for limiting growth of eye length |